I believe the same, the price currently would also include more holders and new buyers, which would mean less shares on the market for shorters to buy back when there is positive news
ACW This biotech stock raised $11M in a risk-off environment. Its Alzheimer's drug could change the game
History-making uranium sample grades and an imminent drill run. Infini Resources is poised to transform in 2025